Replies to post #11210 on GTC Biotherapeutics (fka GTCB)

[Lewis R Goudy]

>Maybe he will voluntarily forgo his annual increase for 2008. That would help.<

All things considered he ought forego his salary outright
and serve for a dollar a year. I have held other firms
that came to dire straits and seen CEO's do just that.
It surely wouldn't hurt and management's relentless lack
of remorse in blithely devouring owner's equity is starting
to stink.

[croumagnon]

"Maybe he will voluntarily forgo his annual increase for 2008."

That would not help much nor will it happen. what would be better is for him to buy shares in the open market for about half his salary, or say 600,000 shares. Now that will send a strong signal of confidence to the street...

Otherwise, this company's future is now hanging in the balance of where the next financing will come from. A solid partnership is what we are all hoping for but I would settle for a buyout at about $0.8 per share right now...

Over time I have developed an aversion to this stock because I think they had the technical goods to make it a good investment but management has messed up big time on the business side. At this rate, by the time they get their business act together, the compatition may have already moved past their potentially lucrative markets and/or we would be a sitting duck for a very low priced takeover with possibly no premium to the trading price...

[go seek]

Could you pls provide the reference
that shows Dr. Cox receives $236K for NABI BOD chair?

i'll look also...

was not Dr Cox also interim CEO, for a period of time w/ NABI?




"Ninety percent of this game is half mental." Yogi Berra